Initiating methotrexate within 2 years of a psoriasis diagnosis is associated with a reduced risk of progressing to PsA.

参考文献：1.《中国银屑病诊疗指南（2023版）》2.中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南（2023版） [J] . 中华皮肤科杂志, 2023, 56(7) : 573-625. DOI: ...

The global Psoriatic Arthritis (PsA) Treatment Market is expected to grow from USD 11,973.7 million in 2024 to USD 25,375.6 ...

Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to ...

Initiated the Phase 3 VELA program of the Nanobody ® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa ...

Research shows that eating antioxidant-rich foods can reduce inflammation and protect against chronic diseases like cancer, ...

A healthy microbiome is fundamental to good health. Numerous products are available on the market to influence the microbiome ...

Biocon share price rose by 2.5% after its arm launched Yesintek, a biosimilar for autoimmune disorders in the US. Approved ...

Arcutis Biotherapeutics Inc.'s stock jumped 8.7% in after-hours trading on Tuesday following a stronger-than-expected ...

Q4 2024 net product revenue for ZORYVE® (roflumilast) was $69.4 million, a 413% increase compared to Q4 of 2023 and a 55% increase compared to Q3 of 2024; driven by strong portfolio demand growth and ...

Discover the latest industry insights at the 2025 Annual Meeting through engaging educational and product-focused sessions. These presentations give exhibiting companies a platform to unveil ...

The former Strictly star, 36, who was diagnosed with the condition in 2023, gave fans a raw and honest update while ...